Plain‑language drug resistant epilepsy research: who benefits from surgery, devices, diets, and emerging treatments.
This study looked at how well a combination of traditional Chinese medicine (TCM) and Western medicine works for people with refractory epilepsy (RE), which is a type of epilepsy that doesn’t respond well to standard treatments.
Researchers studied drug-resistant epilepsy (DRE), which affects people who do not respond to standard seizure medications.
A recent study looked at two different treatments for people with epilepsy caused by a brain condition called focal cortical dysplasia (FCD) that shows up on MRI scans.
This study looked at the long-term quality of life for people who survived a severe type of epilepsy called new onset refractory status epilepticus (NORSE), including a specific form known as febrile infection-related epilepsy syndrome (FIRES).
This study looked at the blood levels of two substances, cannabidiol (CBD) and tetrahydrocannabinol (THC), in children with epilepsy that does not respond to standard treatments.
Researchers studied a specific type of epilepsy linked to mutations in the KCNT1 gene, which causes potassium channels in the brain to become overly active.
Researchers studied two surgical treatments for people with drug-resistant epilepsy: open resective surgery (ORS) and laser interstitial thermal therapy (LITT).
This study looked at how effective and safe the medication lacosamide (LCM) is for children and teenagers with drug-resistant epilepsy (DRE), which means their seizures do not respond well to standard treatments.
This study looked at the healthcare use and costs for people with drug-resistant epilepsy (DRE) who were enrolled in Medicaid and received a neurostimulator implant.